Akero Therapeutics stock initiated with Buy rating at TD Cowen on MASH treatment potential – RP Digital

Business

Akero Therapeutics stock initiated with Buy rating at TD Cowen on MASH treatment potential

August 4, 20251 min0

Akero Therapeutics stock initiated with Buy rating at TD Cowen on MASH treatment potential

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

BancFirst declares quarterly dividend and trust interest payment

rpdigitalAugust 28, 20250

Jefferies raises Ollie's Bargain Outlet stock price target to $135 on strong growth

rpdigitalAugust 28, 20250